Point72 Hong Kong’s Tectonic Therapeutic TECX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-81
Closed -$1K 2484
2022
Q2
$1K Sell
81
-186
-70% -$2.19K ﹤0.01% 1831
2022
Q1
$4K Buy
267
+18
+7% +$372 ﹤0.01% 1700
2021
Q4
$11K Sell
249
-133
-35% -$7.64K ﹤0.01% 1626
2021
Q3
$26K Buy
+382
New +$31.3K ﹤0.01% 1654
2020
Q1
Sell
-106
Closed -$26K 1422
2019
Q4
$26K Buy
+106
New +$20.4K 0.01% 835

Other funds holding TECX

Point72 Hong Kong's TECX Position: Q3 2022 in Review

Point72 Hong Kong sold out of Tectonic Therapeutic (TECX) in Q3 2022, closing a stake of 81 shares — an estimated $1K sold.

Point72 Hong Kong first reported a position in TECX in Q4 2019 and held it in 5 quarters. The position peaked at $26K in Q3 2021. 54 funds tracked by Wall St. Rank hold TECX as of Q3 2022.

  • Point72 Hong Kong reported no remaining Tectonic Therapeutic position as of Q3 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 81 Tectonic Therapeutic shares in Q3 2022, an estimated $1K.
  • Point72 Hong Kong first reported a position in Tectonic Therapeutic in Q4 2019 and held it in 5 quarters.
  • Point72 Hong Kong's Tectonic Therapeutic position peaked at $26K in Q3 2021.
  • 54 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q3 2022.

Based on Point72 Hong Kong's 13F filing for Q3 2022, filed 14 Nov 2022.